BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 19168385)

  • 1. Role of Pseudomonas aeruginosa type III effectors in disease.
    Engel J; Balachandran P
    Curr Opin Microbiol; 2009 Feb; 12(1):61-6. PubMed ID: 19168385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa ExoS and ExoT.
    Barbieri JT; Sun J
    Rev Physiol Biochem Pharmacol; 2004; 152():79-92. PubMed ID: 15375697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.
    Henriksson ML; Sundin C; Jansson AL; Forsberg A; Palmer RH; Hallberg B
    Biochem J; 2002 Nov; 367(Pt 3):617-28. PubMed ID: 12132999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa infection of airway epithelial cells modulates expression of Kruppel-like factors 2 and 6 via RsmA-mediated regulation of type III exoenzymes S and Y.
    O'Grady EP; Mulcahy H; O'Callaghan J; Adams C; O'Gara F
    Infect Immun; 2006 Oct; 74(10):5893-902. PubMed ID: 16988269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADP-ribosylation of cyclophilin A by Pseudomonas aeruginosa exoenzyme S.
    DiNovo AA; Schey KL; Vachon WS; McGuffie EM; Olson JC; Vincent TS
    Biochemistry; 2006 Apr; 45(14):4664-73. PubMed ID: 16584201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
    Shaver CM; Hauser AR
    Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a novel coinfection system reveals a role for Rac1, H-Ras, and CrkII phosphorylation in Helicobacter pylori-induced host cell actin cytoskeletal rearrangements.
    Brandt S; Shafikhani S; Balachandran P; Jin S; Hartig R; König W; Engel J; Backert S
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):190-205. PubMed ID: 17428306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP-ribosylation by exoenzyme T of Pseudomonas aeruginosa induces an irreversible effect on the host cell cytoskeleton in vivo.
    Sundin C; Hallberg B; Forsberg A
    FEMS Microbiol Lett; 2004 May; 234(1):87-91. PubMed ID: 15109724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin cytoskeleton disruption by ExoY and its effects on Pseudomonas aeruginosa invasion.
    Cowell BA; Evans DJ; Fleiszig SM
    FEMS Microbiol Lett; 2005 Sep; 250(1):71-6. PubMed ID: 16039071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ExoU is a potent intracellular phospholipase.
    Sato H; Frank DW
    Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa ExoT Induces Mitochondrial Apoptosis in Target Host Cells in a Manner That Depends on Its GTPase-activating Protein (GAP) Domain Activity.
    Wood SJ; Goldufsky JW; Bello D; Masood S; Shafikhani SH
    J Biol Chem; 2015 Nov; 290(48):29063-73. PubMed ID: 26451042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
    Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ExoS and ExoT ADP ribosyltransferase activities mediate Pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival.
    Sun Y; Karmakar M; Taylor PR; Rietsch A; Pearlman E
    J Immunol; 2012 Feb; 188(4):1884-95. PubMed ID: 22250085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN.
    Sundin C; Thelaus J; Bröms JE; Forsberg A
    Microb Pathog; 2004 Dec; 37(6):313-22. PubMed ID: 15619427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
    Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
    Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exotoxin S secreted by internalized Pseudomonas aeruginosa delays lytic host cell death.
    Kroken AR; Gajenthra Kumar N; Yahr TL; Smith BE; Nieto V; Horneman H; Evans DJ; Fleiszig SMJ
    PLoS Pathog; 2022 Feb; 18(2):e1010306. PubMed ID: 35130333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo.
    Vance RE; Rietsch A; Mekalanos JJ
    Infect Immun; 2005 Mar; 73(3):1706-13. PubMed ID: 15731071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
    Lee VT; Smith RS; Tümmler B; Lory S
    Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of glutathione on the gene expression of exoY and exoS in Pseudomonas aeruginosa.
    Zhang Y; Wei Y
    Wei Sheng Wu Xue Bao; 2009 May; 49(5):603-8. PubMed ID: 19637567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.